SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-22-004974
Filing Date
2022-02-14
Accepted
2022-02-11 19:18:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G srpt12312021.txt SC 13G 9032
  Complete submission text file 0001140361-22-004974.txt   11217
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 22623762
SIC: 2834 Pharmaceutical Preparations

Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G